|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM16103411X |
003 |
DE-627 |
005 |
20250207042017.0 |
007 |
tu |
008 |
231223s2006 xx ||||| 00| ||eng c |
028 |
5 |
2 |
|a pubmed25n0537.xml
|
035 |
|
|
|a (DE-627)NLM16103411X
|
035 |
|
|
|a (NLM)16511797
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Yamato, Osamu
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Use of amnion and placenta in neonatal screening for canine GM1-gangliosidosis and the risk of diagnostic misclassifications
|
264 |
|
1 |
|c 2006
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 05.05.2006
|
500 |
|
|
|a Date Revised 09.11.2019
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a BACKGROUND: A closed breeding colony of Shiba dogs with GM1-gangliosidosis is maintained at Hokkaido University (Sapporo, Japan). Neonatal genotyping is essential to control the breeding colony genetically as an animal model for the human disease
|
520 |
|
|
|a OBJECTIVES: The purpose of the present study was to determine the utility of amnion and placenta in the neonatal screening or diagnosis for canine GM1-gangliosidosis
|
520 |
|
|
|a METHODS: Twenty neonatal Shiba dogs of a pedigree with GM1- gangliosidosis were differentiated into 3 genotypes--normal, heterozygous, and affected dogs--by using a previously reported DNA mutation assay. Acid beta-galactosidase activity was measured in amnion and placenta and compared among the 3 genotypes
|
520 |
|
|
|a RESULTS: The level of beta-galactosidase activity in the amnion of affected dogs was negligible and <2% of the mean activity in normal dogs; there was no significant difference among the 3 genotypes. In placenta, beta-galactosidase activity was significantly different among all the genotypes; however, there was wide overlap in enzyme activity between normal and heterozygous dogs. The level of activity in affected dogs was relatively high and >10% of the mean activity in normal dogs. The DNA mutation assay gave correct information about genotype with genomic DNA extracted from amnion but ambiguous information with DNA from placenta
|
520 |
|
|
|a CONCLUSIONS: Amnion and placenta were not useful as enzyme sources in neonatal screening in canine GM1-gangliosidosis because of the risk of misdiagnosis. DNA from amnion is applicable as a template for genotyping, whereas placenta should not be used because canine placenta contains maternal cells
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a beta-Galactosidase
|2 NLM
|
650 |
|
7 |
|a EC 3.2.1.23
|2 NLM
|
700 |
1 |
|
|a Jo, Eun-Og
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Satoh, Hiroyuki
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Yamauchi, Toyofumi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Kobayashi, Asogi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Yamasaki, Masahiro
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Maede, Yoshimitsu
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Veterinary clinical pathology
|d 1975
|g 35(2006), 1 vom: 01. März, Seite 91-4
|w (DE-627)NLM098159984
|x 0275-6382
|7 nnns
|
773 |
1 |
8 |
|g volume:35
|g year:2006
|g number:1
|g day:01
|g month:03
|g pages:91-4
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 35
|j 2006
|e 1
|b 01
|c 03
|h 91-4
|